Showing results (51-60 of 131) with videos related to

Sort By:
Pageof 14
Plos Biology|September 28, 2011
ESRRA-C11orf20 is a recurrent gene fusion in serous ovarian carcinomaJulia Salzman, Robert J Marinelli, Peter L Wang, et al.
Molecular Therapy. Methods & Clinical Development|March 5, 2020
A Rapid and Sensitive Nucleic Acid Amplification Technique for <i>Mycoplasma</i> Screening of Cell Therapy ProductsLisa Dreolini, Mark Cullen, Eric Yung, et al.
Plos One|May 19, 2016
Low Mutation Burden in Ovarian Cancer May Limit the Utility of Neoantigen-Targeted VaccinesSpencer D Martin, Scott D Brown, Darin A Wick, et al.
The Journal of Pathology|September 22, 2012
Clonal evolution of high-grade serous ovarian carcinoma from primary to recurrent diseaseMauro Castellarin, Katy Milne, Thomas Zeng, et al.
Journal of Translational Medicine|February 29, 2012
Absolute lymphocyte count is associated with survival in ovarian cancer independent of tumor-infiltrating lymphocytesKaty Milne, Cheryl Alexander, John R Webb, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2019
Cancer stemness, intratumoral heterogeneity, and immune response across cancersAlex Miranda, Phineas T Hamilton, Allen W Zhang, et al.
BMC Cancer|September 6, 2017
Programmed cell death ligand 1 cut-point is associated with reduced disease specific survival in resected pancreatic ductal adenocarcinomaBasile Tessier-Cloutier, Steve E Kalloger, Mohammad Al-Kandari, et al.
Pageof 14